We believe that our data, which show that NLRX1 positively regulates apoptosis induced by intrinsic signals, such as glycolysis inhibition, explain this apparent paradox: because cancer cells heavily rely on glycolysis, they are very sensitive to glycolysis inhibition. Here, NLRX1 is linked to cancer.